As the global prevalence of dementia is quickly rising, there is an unprecedented need to characterise the impact of genetic predisposition (e.g., Apolipoprotein E (APOE) polymorphism [4]) and modifiable risk factors on ADRD-vulnerable brain structures before the onset of cognitive decline. This evidence concerns the gene APOE and dementia.